Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Neurology

Why Is GNE Myopathy Often Misdiagnosed as CMT or sIBM?

At a Glance

GNE myopathy is frequently misdiagnosed as CMT due to shared symptoms like foot drop, or as sIBM because both show rimmed vacuoles on a muscle biopsy. Doctors differentiate them by checking for nerve damage, age of onset, quadriceps sparing, and confirming with genetic testing.

In this answer

3 sections

01

The Overlap with Charcot-Marie-Tooth (CMT) Disease

02

The Overlap with Sporadic Inclusion Body Myositis (sIBM)

03

Reaching the Correct Diagnosis

It is incredibly common for patients with GNE myopathy to face a diagnostic delay of five years or more [1][2]. Because GNE myopathy is a very rare disease, doctors frequently mistake its early symptoms for more common conditions that look similar on the surface [1]. If you were originally told you had Charcot-Marie-Tooth (CMT) disease or sporadic Inclusion Body Myositis (sIBM), it is because your early symptoms—like foot drop and specific findings on a muscle biopsy—mimic these exact conditions [3][4]. Understanding why these overlaps happen can help validate the frustrating and confusing journey you may have experienced before receiving your correct diagnosis.

The Overlap with Charcot-Marie-Tooth (CMT) Disease

CMT is one of the most common inherited neurological disorders. For many people with GNE myopathy, the very first noticeable symptom is bilateral (affecting both sides) foot drop—difficulty lifting the front part of the foot, which can cause tripping or changes in how you walk [3][5]. Because CMT frequently presents with foot drop in young adults, doctors often suspect it first [6].

  • The Confusion: Both conditions cause significant weakness in the distal muscles (the muscles furthest from the center of the body, like the lower legs and feet) [7].
  • How They Are Differentiated: The key difference is the root cause of the weakness. CMT is a neuropathy (a nerve issue), while GNE myopathy is a myopathy (a muscle issue) [7]. To tell them apart, doctors use Electromyography (EMG) and Nerve Conduction Studies (NCS). An EMG and NCS in CMT will show a “neurogenic” pattern indicating nerve damage [7]. An EMG in GNE myopathy typically shows a “myopathic” pattern—meaning the nerves are fine, but the muscle tissue itself is damaged [2][8]. Although, in rare cases, GNE myopathy can show nerve involvement, making the puzzle even harder to solve [9][10].

The Overlap with Sporadic Inclusion Body Myositis (sIBM)

sIBM is a progressive muscle-wasting disease that also causes weakness in the arms and legs. If you had a muscle biopsy early in your diagnostic journey, the results might have pointed your medical team toward sIBM [4][7].

  • The Confusion: When pathologists examine a muscle biopsy from a patient with GNE myopathy under a microscope, they often see rimmed vacuoles—small, empty spaces or “holes” inside the muscle fibers surrounded by cellular debris [4][7]. These rimmed vacuoles are considered a hallmark sign of sIBM, leading many doctors to make an immediate assumption [4][7].
  • How They Are Differentiated: Despite sharing the feature of rimmed vacuoles, sIBM and GNE myopathy are very different diseases [11].
    • Age of Onset: GNE myopathy typically begins in young adulthood (late teens to early 30s), whereas sIBM almost exclusively affects older adults over the age of 50 [12][13][14].
    • Inflammation: sIBM involves heavy inflammation in the muscles [4][15]. GNE myopathy typically does not [4]. If you were previously prescribed strong anti-inflammatory or immunosuppressive medications for a suspected sIBM diagnosis, it is important to speak with your doctor about how to safely manage or taper off these treatments now that your true diagnosis is known.
    • Quadriceps Sparing: GNE myopathy has a unique clinical “red flag”: it typically spares the quadriceps (the large muscles on the front of your thighs) even as the lower legs become very weak [16][17]. sIBM, on the other hand, often severely affects the quadriceps [4][18].

Reaching the Correct Diagnosis

Because GNE myopathy can disguise itself as CMT or sIBM, arriving at the right answer often requires a specialist who knows what specific clues to look for [1][2]. Recognizing the combination of young-onset foot drop, quadriceps-sparing muscle weakness, and rimmed vacuoles on a biopsy eventually points an expert away from CMT or sIBM [19][17]. Ultimately, the definitive proof comes from genetic testing to identify mutations in both copies of the GNE gene [20][3]. Because it is a genetic condition, achieving a confirmed diagnosis not only helps tailor your care, but also informs whether siblings or other family members might benefit from genetic counseling [20]. If you spent years bouncing between incorrect diagnoses, know that this is a common part of the GNE myopathy story, caused by the complex biological overlaps of these rare conditions [1].

Common questions in this guide

Why is GNE myopathy often initially diagnosed as Charcot-Marie-Tooth (CMT) disease?
Both conditions frequently cause foot drop and weakness in the lower legs and feet in young adults. Because CMT is a much more common neurological disorder, doctors often suspect it first when these symptoms appear.
How do doctors tell the difference between GNE myopathy and CMT?
Doctors use Electromyography (EMG) and Nerve Conduction Studies (NCS) to tell them apart. CMT is a neuropathy that shows nerve damage, while GNE myopathy typically shows a myopathic pattern, meaning the muscle tissue itself is damaged but the nerves are fine.
Why does a muscle biopsy lead to an sIBM misdiagnosis?
When a pathologist examines a muscle biopsy from someone with GNE myopathy, they often see rimmed vacuoles, which are small empty spaces in the muscle fibers. Because rimmed vacuoles are a hallmark sign of sIBM, doctors frequently assume sIBM is the correct diagnosis.
What are the main differences between GNE myopathy and sIBM?
GNE myopathy typically starts in young adulthood, lacks heavy muscle inflammation, and uniquely spares the quadriceps muscles. In contrast, sIBM almost exclusively affects adults over 50, involves significant muscle inflammation, and causes severe quadriceps weakness.
How is a definitive diagnosis of GNE myopathy finally made?
While physical exams and muscle biopsies provide important clues, definitive proof requires genetic testing. A confirmed diagnosis is made by identifying mutations in both copies of the GNE gene.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my history, are there any lingering signs of nerve involvement or inflammation that we need to monitor, or is everything clearly linked to GNE myopathy?
  2. 2.How does my specific GNE gene mutation align with the typical progression of the disease?
  3. 3.Should my siblings or children consider genetic counseling or testing, given my initial misdiagnoses?
  4. 4.Now that we have the correct diagnosis, what is the best strategy for preserving the strength in my quadriceps and other unaffected muscles?
  5. 5.How do we safely adjust or stop any medications I was prescribed for my previous misdiagnoses?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Diet or Supplements Treat GNE Myopathy?Does GNE Myopathy Cause Sleep Apnea? Symptoms & TestingHow Fast Does GNE Myopathy Progress to a Wheelchair?Is Acenobel Available for GNE Myopathy Outside Japan?Is Exercise Safe for GNE Myopathy? Workout GuidelinesIs GNE Myopathy Hereditary?ManNAc vs. Acenobel: GNE Myopathy Therapies ComparedWhat is Quadriceps Sparing in GNE Myopathy?When Should I Get AFO Braces for GNE Myopathy Foot Drop?Who is Most at Risk for Developing GNE Myopathy?Why Does GNE Myopathy Cause Low Platelets?

References

References (20)
  1. 1

    GNE myopathy: History, etiology, and treatment trials.

    Mullen J, Alrasheed K, Mozaffar T

    Frontiers in neurology 2022; (13()):1002310 doi:10.3389/fneur.2022.1002310.

    PMID: 36330422
  2. 2

    Long term clinical follow-up and natural history in a cohort of Italian patients with GNE myopathy: the experience of a single centre.

    Pugliese A, Sframeli M, D'Ambrosio P, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(9)):4645-4652 doi:10.1007/s10072-025-08265-w.

    PMID: 40447857
  3. 3

    GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges.

    Carrillo N, Malicdan MC, Huizing M

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2018; (15(4)):900-914 doi:10.1007/s13311-018-0671-y.

    PMID: 30338442
  4. 4

    Sporadic Inclusion Body Myositis and Other Rimmed Vacuolar Myopathies.

    Weihl CC

    Continuum (Minneapolis, Minn.) 2019; (25(6)):1586-1598 doi:10.1212/CON.0000000000000790.

    PMID: 31794461
  5. 5

    Neuromuscular Mimics of Entrapment Neuropathies of Upper Extremities.

    Gilchrist JM, Dandapat S

    Hand (New York, N.Y.) 2020; (15(5)):599-607 doi:10.1177/1558944719898801.

    PMID: 32020820
  6. 6

    Early and consistent pattern of proximal weakness in GNE myopathy.

    Khadilkar SV, Chaudhari AD, Singla MB, et al.

    Muscle & nerve 2021; (63(2)):199-203 doi:10.1002/mus.27117.

    PMID: 33197058
  7. 7

    Differential Diagnoses of Inclusion Body Myositis.

    Vivekanandam V, Bugiardini E, Merve A, et al.

    Neurologic clinics 2020; (38(3)):697-710 doi:10.1016/j.ncl.2020.03.014.

    PMID: 32703477
  8. 8

    A novel heterozygous mutation in the C-terminal region of HSPB8 leads to limb-girdle rimmed vacuolar myopathy.

    Nicolau S, Liewluck T, Elliott JL, et al.

    Neuromuscular disorders : NMD 2020; (30(3)):236-240 doi:10.1016/j.nmd.2020.02.005.

    PMID: 32165108
  9. 9

    Different electrophysiology patterns in GNE myopathy.

    Liu X, Zhang Y, Zhang S, et al.

    Orphanet journal of rare diseases 2022; (17(1)):206 doi:10.1186/s13023-022-02355-0.

    PMID: 35590323
  10. 10

    Expanding the clinicopathological-genetic spectrum of GNE myopathy by a Chinese neuromuscular centre.

    Zhang KY, Duan HQ, Li QX, et al.

    Journal of cellular and molecular medicine 2021; (25(22)):10494-10503 doi:10.1111/jcmm.16978.

    PMID: 34676965
  11. 11

    Pathological findings in sporadic inclusion body myositis and GNE myopathy.

    Zhang Y, Pu C, Lu X, et al.

    International journal of clinical and experimental pathology 2018; (11(5)):2907-2911.

    PMID: 31938415
  12. 12

    Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double-blind, placebo-controlled, cross-over trial.

    Coudert JD, Slater N, Sooda A, et al.

    Clinical & translational immunology 2022; (11(9)):e1416 doi:10.1002/cti2.1416.

    PMID: 36188123
  13. 13

    Inclusion body myositis in the rheumatology clinic.

    Balakrishnan A, Aggarwal R, Agarwal V, Gupta L

    International journal of rheumatic diseases 2020; (23(9)):1126-1135 doi:10.1111/1756-185X.13902.

    PMID: 32662192
  14. 14

    Preserved Forearm and Hand Muscles and Diaphragm with Mild Cardiac and Respiratory Involvement in a Patient with GNE Myopathy Harboring Homozygous Variants in GNE (c.1807G>C, p.V603L) over Four Decades after the Onset.

    Sakai K, Yamada S, Higuchi Y, Nishino I

    Internal medicine (Tokyo, Japan) 2025; (64(10)):1586-1590 doi:10.2169/internalmedicine.4538-24.

    PMID: 39428522
  15. 15

    Association between muscle strength, histopathology, and magnetic resonance imaging in sporadic inclusion body myositis.

    Dahlbom K, Geijer M, Oldfors A, Lindberg C

    Acta neurologica Scandinavica 2019; (139(2)):177-182 doi:10.1111/ane.13040.

    PMID: 30347435
  16. 16

    [GNE myopathy].

    Urtizberea JA, Béhin A

    Medecine sciences : M/S 2015; (31 Spec No 3()):20-7 doi:10.1051/medsci/201531s306.

    PMID: 26546927
  17. 17

    GNE Myopathy: Two Clusters with History and Several Founder Mutations.

    Argov Z, Mitrani Rosenbaum S

    Journal of neuromuscular diseases 2015; (2(s2)):S73-S76 doi:10.3233/JND-150087.

    PMID: 27858758
  18. 18

    A Rare Case of Sporadic Inclusion Body Myositis (s-IBM).

    Acharya S, Shukla S, Kitey P, et al.

    Journal of clinical and diagnostic research : JCDR 2016; (10(1)):OD07-8 doi:10.7860/JCDR/2016/14902.7111.

    PMID: 26894112
  19. 19

    Comparison of whole-body muscle imaging findings between GNE myopathy and other young adult-onset hereditary myopathies.

    Boonsri P, Yamutai S, Tanutit P, et al.

    PloS one 2026; (21(1)):e0341031 doi:10.1371/journal.pone.0341031.

    PMID: 41575995
  20. 20

    Identification of an Alu element-mediated deletion in the promoter region of GNE in siblings with GNE myopathy.

    Garland J, Stephen J, Class B, et al.

    Molecular genetics & genomic medicine 2017; (5(4)):410-417 doi:10.1002/mgg3.300.

    PMID: 28717665

This page provides educational information about GNE myopathy misdiagnoses. Always consult a neurologist or geneticist regarding your specific symptoms, biopsy results, and diagnosis.

Get notified when new evidence is published on GNE myopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.